HR 3082 United States House · 119th Congress

Evidence-Based Drug Policy Act of 2025

This bill repeals a specific provision (section 704(b)(12)) from the 1998 Office of National Drug Control Policy Reauthorization Act. The text provided does not explain what policy or requirement was contained in the repealed section, so the specific policy change or who it directly affected cannot be determined from the given context. Without details on the repealed provision's content, a summary of mechanisms, key provisions, or affected parties cannot be accurately provided. The bill appears to be a procedural repeal with no additional substantive provisions described in the excerpt.
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2025
Committee Review
Floor Vote
President
Introduced Apr 29, 2025 Last action Apr 29, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Apr 29, 2025
Committee
Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Apr 29, 2025
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors

Sponsors